This report demonstrates consensus on quality of life instruments in oncology, implying vital input from stakeholders.
This report is written as a product of the project “Quality of Life in Oncology: measuring what matters forcancer patients and survivors in Europe (EUonQoL)”. This project is funded by the European Union.The authors would like to express their gratitude to everyone that participated in the consensus processof the EUonQoL-Kit, including researchers involved in the EUonQoL project, members of the EUonQoLStakeholder Board, and all individuals that participated in the Stakeholder Forum as external stakeholders.Additionally, we would like to thank the EUonQoL Executive Committee for providing us with valuablefeedback on the final draft of this report.
No takes yet. Share an insight, caveat, or question.
Engelaar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: